Libertyville, IL, United States of America

David L Arendsen

This inventor holds 17 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Abbott Laboratories Corporation. Active years: 1976-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David L Arendsen. Retrieved from https://idiyas.com/inventor/david-l-arendsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 82.4

 

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 405(Granted Patents)


Company Filing History:


Years Active: 1976-2003

Loading Chart...
Loading Chart...
Areas of Expertise:
Glucocorticoid Receptor Antagonists
Anti-Inflammatory Compounds
Squalene Synthase Inhibitors
Aminomethyl-Chroman
Adrenergic Receptor Agonists
Pyrazolyl Amino Imidazolines
Aminoalkyl Dihydronaphthalenes
6A-Azacannabinoids
Fraction Collector Turntable
Dust Cover Unit
5-Hydroxy Benzopyrans
Phthalans
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David L. Arendsen

Introduction

David L. Arendsen is a prominent inventor based in Libertyville, IL (US), known for his significant contributions to the field of diabetes treatment. With a remarkable portfolio of 17 patents, he has made strides in developing innovative solutions that address critical health challenges.

Latest Patents

Among his latest patents are "Glucocorticoid receptor antagonists for treatment of diabetes" and "Glucocorticoid receptor modulators." These inventions reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

David L. Arendsen has built a successful career at Abbott Laboratories Corporation, where he has been instrumental in research and development. His work has not only contributed to the company's reputation but has also had a lasting impact on the healthcare industry.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including John F. DeBernardis and Martin Winn. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

David L. Arendsen's contributions to the field of diabetes treatment through his patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…